Oncogene-induced replication stress has been recognized as a major cause of genome instability in cancer cells. Increased expression of cyclin E1 caused by amplification of the CCNE1 gene is a common cause of replication stress in various cancers. Protein phosphatase magnesium-dependent 1 delta (PPM1D) is a negative regulator of p53 and has been implicated in termination of the cell cycle checkpoint. Amplification of the PPM1D gene or frameshift mutations in its final exon promote tumorigenesis. Here, we show that PPM1D activity further increases the replication stress caused by overexpression of cyclin E1. In particular, we demonstrate that cells expressing a truncated mutant of PPM1D progress faster from G1 to S phase and fail to complete licensing of the replication origins. In addition, we show that transcription-replication collisions and replication fork slowing caused by CCNE1 overexpression are exaggerated in cells expressing the truncated PPM1D. Finally, replication speed and accumulation of focal DNA copy number alterations caused by induction of CCNE1 expression was rescued by pharmacological inhibition of PPM1D. We propose that increased activity of PPM1D suppresses the checkpoint function of p53 and thus promotes genome instability in cells expressing the CCNE1 oncogene.

Department of Medical Oncology University Medical Center Groningen University of Groningen The Netherlands

Department of Pathology and Medical Biology University Medical Center Groningen University of Groningen The Netherlands

Institute of Molecular Cancer Research University of Zurich Switzerland

Laboratory of Cancer Cell Biology Institute of Molecular Genetics Czech Academy of Sciences Prague Czech Republic

Zobrazit více v PubMed

Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74. PubMed

Zeman MK, Cimprich KA. Causes and consequences of replication stress. Nat Cell Biol. 2014;16:2–9. PubMed PMC

Bartkova J, Hořejší Z, Koed K, Krämer A, Tort F, Zieger K, et al. DNA damage response as a candidate anti‐cancer barrier in early human tumorigenesis. Nature. 2005;434:864–70. PubMed

Bartkova J, Rezaei N, Liontos M, Karakaidos P, Kletsas D, Issaeva N, et al. Oncogene‐induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpoints. Nature. 2006;444:633–7. PubMed

Cancer Genome Atlas Research Network . Integrated genomic analyses of ovarian carcinoma. Nature. 2011;474:609–15. PubMed PMC

Cancer Genome Atlas Network . Comprehensive molecular portraits of human breast tumours. Nature. 2012;490:61–70. PubMed PMC

Guerrero Llobet S, van der Vegt B, Jongeneel E, Bense RD, Zwager MC, Schröder CP, et al. Cyclin E expression is associated with high levels of replication stress in triple‐negative breast cancer. NPJ Breast Cancer. 2020;6:40. PubMed PMC

Spruck CH, Won KA, Reed SI. Deregulated cyclin E induces chromosome instability. Nature. 1999;401:297–300. PubMed

Jones RM, Mortusewicz O, Afzal I, Lorvellec M, García P, Helleday T, et al. Increased replication initiation and conflicts with transcription underlie cyclin E‐induced replication stress. Oncogene. 2013;32:3744–53. PubMed

Fagundes R, Teixeira LK. Cyclin E/CDK2: DNA replication, replication stress and genomic instability. Front Cell Dev Biol. 2021;9:774845. PubMed PMC

Bester Assaf C, Roniger M, Oren YS, Im MM, Sarni D, Chaoat M, et al. Nucleotide deficiency promotes genomic instability in early stages of cancer development. Cell. 2011;145:435–46. PubMed PMC

Macheret M, Halazonetis TD. Intragenic origins due to short G1 phases underlie oncogene‐induced DNA replication stress. Nature. 2018;555:112–6. PubMed PMC

Toledo LI, Altmeyer M, Rask MB, Lukas C, Larsen DH, Povlsen LK, et al. ATR prohibits replication catastrophe by preventing global exhaustion of RPA. Cell. 2013;155:1088–103. PubMed

Kok YP, Guerrero Llobet S, Schoonen PM, Everts M, Bhattacharya A, Fehrmann RSN, et al. Overexpression of cyclin E1 or Cdc25A leads to replication stress, mitotic aberrancies, and increased sensitivity to replication checkpoint inhibitors. Oncogenesis. 2020;9:88. PubMed PMC

Zhang CZ, Spektor A, Cornils H, Francis JM, Jackson EK, Liu S, et al. Chromothripsis from DNA damage in micronuclei. Nature. 2015;522:179–84. PubMed PMC

El‐Deiry WS, Harper JW, O'Connor PM, Velculescu VE, Canman CE, Jackman J, et al. WAF1/CIP1 is induced in p53‐mediated G1 arrest and apoptosis. Cancer Res. 1994;54:1169–74. PubMed

Jackson SP, Bartek J. The DNA‐damage response in human biology and disease. Nature. 2009;461:1071–8. PubMed PMC

Nevis KR, Cordeiro‐Stone M, Cook JG. Origin licensing and p53 status regulate Cdk2 activity during G1. Cell Cycle. 2009;8:1952–63. PubMed PMC

Matson JP, House AM, Grant GD, Wu H, Perez J, Cook JG. Intrinsic checkpoint deficiency during cell cycle re‐entry from quiescence. J Cell Biol. 2019;218:2169–84. PubMed PMC

Klusmann I, Rodewald S, Müller L, Friedrich M, Wienken M, Li Y, et al. p53 activity results in DNA replication fork processivity. Cell Rep. 2016;17:1845–57. PubMed

Hampp S, Kiessling T, Buechle K, Mansilla SF, Thomale J, Rall M, et al. DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression. Proc Natl Acad Sci USA. 2016;113:E4311–9. PubMed PMC

Giansanti C, Manzini V, Dickmanns A, Dickmanns A, Palumbieri MD, Sanchi A, et al. MDM2 binds and ubiquitinates PARP1 to enhance DNA replication fork progression. Cell Rep. 2022;39:110879. PubMed

Minella AC, Swanger J, Bryant E, Welcker M, Hwang H, Clurman BE. p53 and p21 form an inducible barrier that protects cells against cyclin E‐cdk2 deregulation. Curr Biol. 2002;12:1817–27. PubMed

Loeb KR, Kostner H, Firpo E, Norwood T, Tsuchiya KD, Clurman BE, et al. A mouse model for cyclin E‐dependent genetic instability and tumorigenesis. Cancer Cell. 2005;8:35–47. PubMed

Lindqvist A, de Bruijn M, Macurek L, Brás A, Mensinga A, Bruinsma W, et al. Wip1 confers G2 checkpoint recovery competence by counteracting p53‐dependent transcriptional repression. EMBO J. 2009;28:3196–206. PubMed PMC

Jaiswal H, Benada J, Müllers E, Akopyan K, Burdova K, Koolmeister T, et al. ATM/Wip1 activities at chromatin control Plk1 re‐activation to determine G2 checkpoint duration. EMBO J. 2017;36:2161–76. PubMed PMC

Shaltiel IA, Aprelia M, Saurin AT, Chowdhury D, Kops GJPL, Voest EE, et al. Distinct phosphatases antagonize the p53 response in different phases of the cell cycle. Proc Natl Acad Sci USA. 2014;111:7313–8. PubMed PMC

Bulavin DV, Demidov ON, Saito S, Kauraniemi P, Phillips C, Amundson SA, et al. Amplification of PPM1D in human tumors abrogates p53 tumor‐suppressor activity. Nat Genet. 2002;31:210–5. PubMed

Ruark E, Snape K, Humburg P, Loveday C, Bajrami I, Brough R, et al. Mosaic PPM1D mutations are associated with predisposition to breast and ovarian cancer. Nature. 2013;493:406–10. PubMed PMC

Kleiblova P, Shaltiel IA, Benada J, Ševčík J, Pecháčková S, Pohlreich P, et al. Gain‐of‐function mutations of PPM1D/Wip1 impair the p53‐dependent G1 checkpoint. J Cell Biol. 2013;201:511–21. PubMed PMC

Zhang L, Hsu JI, Goodell MA. PPM1D in solid and hematologic malignancies: friend and foe? Mol Cancer Res. 2022;20:1365–78. PubMed PMC

Burocziova M, Burdova K, Martinikova AS, Kasparek P, Kleiblova P, Danielsen SA, et al. Truncated PPM1D impairs stem cell response to genotoxic stress and promotes growth of APC‐deficient tumors in the mouse colon. Cell Death Dis. 2019;10:818. PubMed PMC

Martinikova AS, Burocziova M, Stoyanov M, Macurek L. Truncated PPM1D prevents apoptosis in the murine thymus and promotes ionizing radiation‐induced lymphoma. Cell. 2020;9:2068. PubMed PMC

Kahn JD, Miller PG, Silver AJ, Sellar RS, Bhatt S, Gibson C, et al. PPM1D truncating mutations confer resistance to chemotherapy and sensitivity to PPM1D inhibition in hematopoietic cells. Blood. 2018;132:1095–105. PubMed PMC

Pechackova S, Burdova K, Benada J, Kleiblova P, Jenikova G, Macurek L. Inhibition of WIP1 phosphatase sensitizes breast cancer cells to genotoxic stress and to MDM2 antagonist nutlin‐3. Oncotarget. 2016;7:14458–75. PubMed PMC

van den Bos H, Spierings DCJ, Taudt A, Bakker B, Porubský D, Falconer E, et al. Single‐cell whole genome sequencing reveals no evidence for common aneuploidy in normal and Alzheimer's disease neurons. Genome Biol. 2016;17:116. PubMed PMC

Bakker B, Taudt A, Belderbos ME, Porubsky D, Spierings DCJ, de Jong TV, et al. Single‐cell sequencing reveals karyotype heterogeneity in murine and human malignancies. Genome Biol. 2016;17:115. PubMed PMC

Chappidi N, Nascakova Z, Boleslavska B, Zellweger R, Isik E, Andrs M, et al. Fork cleavage‐religation cycle and active transcription mediate replication restart after fork stalling at co‐transcriptional R‐loops. Mol Cell. 2020;77:528–41.e8. PubMed

Li QHQ, Cao W, Li J, Wu K, Elshimali Y, Zhu D, et al. PP2Cδ inhibits p300‐mediated p53 acetylation via ATM/BRCA1 pathway to impede DNA damage response in breast cancer. Sci Adv. 2019;5:eaaw8417. PubMed PMC

Hsu JI, Dayaram T, Tovy A, de Braekeleer E, Jeong M, Wang F, et al. PPM1D mutations drive clonal hematopoiesis in response to cytotoxic chemotherapy. Cell Stem Cell. 2018;23:700–13.e6. PubMed PMC

Gaillard H, García‐Muse T, Aguilera A. Replication stress and cancer. Nat Rev Cancer. 2015;15:276–89. PubMed

Halazonetis TD, Gorgoulis VG, Bartek J. An oncogene‐induced DNA damage model for cancer development. Science. 2008;319:1352–5. PubMed

Gilmartin AG, Faitg TH, Richter M, Groy A, Seefeld MA, Darcy MG, et al. Allosteric Wip1 phosphatase inhibition through flap‐subdomain interaction. Nat Chem Biol. 2014;10:181–7. PubMed

Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4. PubMed PMC

Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1. PubMed PMC

Lu X, Ma O, Nguyen TA, Jones SN, Oren M, Donehower LA. The Wip1 phosphatase acts as a gatekeeper in the p53‐Mdm2 autoregulatory loop. Cancer Cell. 2007;12:342–54. PubMed

Lu X, Nannenga B, Donehower LA. PPM1D dephosphorylates Chk1 and p53 and abrogates cell cycle checkpoints. Genes Dev. 2005;19:1162–74. PubMed PMC

Macurek L, Lindqvist A, Voets O, Kool J, Vos HR, Medema RH. Wip1 phosphatase is associated with chromatin and dephosphorylates gammaH2AX to promote checkpoint inhibition. Oncogene. 2010;15(29):2281–91. PubMed

Klusmann I, Wohlberedt K, Magerhans A, Teloni F, Korbel JO, Altmeyer M, et al. Chromatin modifiers Mdm2 and RNF2 prevent RNA:DNA hybrids that impair DNA replication. Proc Natl Acad Sci USA. 2018;115:E11311–20. PubMed PMC

Vassilev LT, Vu BT, Graves B, Carvajal D, Podlaski F, Filipovic Z, et al. In vivo activation of the p53 pathway by small‐molecule antagonists of MDM2. Science. 2004;303:844–8. PubMed

Mei L, Kedziora KM, Song EA, Purvis JE, Cook JG. The consequences of differential origin licensing dynamics in distinct chromatin environments. Nucleic Acids Res. 2022;50:9601–20. PubMed PMC

Flach J, Bakker ST, Mohrin M, Conroy PC, Pietras EM, Reynaud D, et al. Replication stress is a potent driver of functional decline in ageing haematopoietic stem cells. Nature. 2014;512:198–202. PubMed PMC

Conti C, Saccà B, Herrick J, Lalou C, Pommier Y, Bensimon A. Replication fork velocities at adjacent replication origins are coordinately modified during DNA replication in human cells. Mol Biol Cell. 2007;18:3059–67. PubMed PMC

Lukas C, Savic V, Bekker‐Jensen S, Doil C, Neumann B, Sølvhøj Pedersen R, et al. 53BP1 nuclear bodies form around DNA lesions generated by mitotic transmission of chromosomes under replication stress. Nat Cell Biol. 2011;13:243–53. PubMed

Limas J, Littlejohn AN, House AM, Kedziora KM, Mouery BL, Ma B, et al. Quantitative profiling of adaptation to cyclin E overproduction. Life Sci Alliance. 2022;5:e202201378. PubMed PMC

Zeng J, Hills SA, Ozono E, Diffley JFX. Cyclin E‐induced replicative stress drives p53‐dependent whole‐genome duplication. Cell. 2023;186:528–42.e14. PubMed

Fujiwara T, Bandi M, Nitta M, Ivanova EV, Bronson RT, Pellman D. Cytokinesis failure generating tetraploids promotes tumorigenesis in p53‐null cells. Nature. 2005;437:1043–7. PubMed

PPM1D activity promotes cellular transformation by preventing senescence and cell death